Dr.Reddy's Laboratories Ltd (REDY.BO)

REDY.BO on Bombay Stock Exchange

2,958.80INR
21 Oct 2014
Price Change (% chg)

Rs-6.20 (-0.21%)
Prev Close
Rs2,965.00
Open
Rs2,960.60
Day's High
Rs2,974.00
Day's Low
Rs2,927.90
Volume
9,254
Avg. Vol
21,726
52-wk High
Rs3,353.85
52-wk Low
Rs2,250.00

REDY.BO

Chart for REDY.BO

About

Dr. Reddy’s Laboratories Limited (DRL) is an integrated global pharmaceutical company. The Company operates in three segments: Global Generics segment, which includes its prescription and over-the-counter (OTC) drug products business; Pharmaceutical Services and Active Ingredients (PSAI) segment, which consists of its active... (more)

Overall

Beta: 0.34
Market Cap (Mil.): Rs505,347.69
Shares Outstanding (Mil.): 170.37
Dividend: 18.00
Yield (%): 0.61

Financials

  REDY.BO Industry Sector
P/E (TTM): 25.79 32.74 33.38
EPS (TTM): 115.00 -- --
ROI: 21.73 18.26 17.53
ROE: 27.58 18.93 18.34
Search Stocks

Dr.Reddy's rises; filing shows U.S. market share gains

Reuters Market Eye - Shares in Dr.Reddy's Laboratories gain 1.58 percent vs a 0.02 percent fall in the Nifty.

20 Aug 2014

MARKET EYE -India's Dr.Reddy's rises; filing shows U.S. market share gains

* Shares in India's Dr.Reddy's Laboratories gain 1.1 percent vs a 0.2 percent fall in the NSE index. * A filing with the U.S. Securities and Exchange Commission on Monday shows market share gains in key drugs in the U.S. market, analysts say. (http://1.usa.gov/1tk9u78) (abhishek.vishnoi@thomsonreuters.com / abhishek.vishnoi.thomsonreuters.com@reuters.net)

20 Aug 2014

MARKET EYE -India's Dr. Reddy's operating profit may lag estimates-StarMine

* India's Dr.Reddy's Laboratories Ltd April-June operating profit may lag consensus, Thomson Reuters StarMine's SmartEstimates shows. * Dr.Reddy's may report operating profit of 7.42 billion rupees ($123.3 million) as per SmartEstimates, versus the consensus mean of 7.70 billion rupees. * Dr.Reddy's reports results later in the day. * Shares up 0.3 percent as of 0500 GMT. ($1 = 60.1700 Indian Rupees) (abhishek.vishnoi@thomsonreuters.com / abhishek.vishnoi.thomsonreuters.com@reuters.net)

30 Jul 2014

Dr. Reddy's gains as worries about spending ease

Reuters Market Eye - Shares of Dr. Reddy's Laboratories rise, adding to Friday's 1.8 percent gain, after the drugmaker's annual report last week provided key details about spending on building capacity, raising hopes that expenses would reduce after FY16, dealers say.

30 Jun 2014

MARKET EYE-India's Dr. Reddy's gains as worries about spending ease

* Shares of India's Dr. Reddy's Laboratories up 1 percent, adding to Friday's 1.8 percent gain, after the drugmaker's annual report last week provided key details about spending on building capacity, raising hopes that expenses would reduce after FY16, dealers say. * Dr. Reddy's said in its annual report filed with the U.S. Securities and Exchange Commission that the company would finance expansion plans through operating cash flow and through cash and other investments, and that the majority of

30 Jun 2014

Earnings vs. Estimates

Search Stocks